Despite a steep drop in hepatitis B among children, why is there still opposition to the vaccine?
The hepatitis B vaccine has dramatically lowered childhood infection rates worldwide, but despite its effectiveness, some sectors remain hesitant or resistant to its use. When the hepatitis B vaccine was launched, it marked a milestone in the battle against a virus that had caused numerous chronic infections and associated issues such as liver ailments and cancer. Through time, research consistently demonstrated that this preventive approach is among the most effective public health methods available. In nations where vaccination programs have been extensively carried out, infection rates among children have decreased substantially, providing protection to future generations and lessening the worldwide…